7-Day Holter Monitoring Captured More Major Arrhythmias in Children
A longer ambulatory recording window changed the diagnostic picture in pediatric arrhythmia evaluation. In this single-center study from National Taiwan University Children’s Hospital, 7-day Holter monitoring detected major arrhythmias more often than either a 24-hour Holter strip or 7-day event recording, a difference that carries clear practical weight in children whose symptoms are intermittent and easy to miss during short surveillance windows.
The cohort included 435 patients younger than 18 years, with a mean age of 12.3 years and a slight female predominance. Mean analyzable monitoring time reached 4.9 days, which is important because real-world wear time rarely maps neatly onto the full intended schedule. Pediatric rhythm problems often arrive in fragments: brief palpitations, a single syncopal episode, an isolated bradycardic spell, or a parent’s description of a “flutter” that is gone by the time the child reaches care. A 24-hour snapshot can easily miss those events when they occur outside the recording window or when the symptom burden is too sparse to trigger capture.
Among 411 children who used the event recorder function, 10.7% had symptom-correlated arrhythmias. In other words, one in about nine children who activated the recorder had a rhythm abnormality that lined up with symptoms. That finding reinforces the value of pairing patient-triggered recording with continuous surveillance, especially when complaints are episodic rather than persistent. In children, symptom-rhythm correlation often determines whether the next step is reassurance, medication, electrophysiology referral, or simple observation.
The clearest separation emerged in major arrhythmia detection. 7-day Holter monitoring identified major arrhythmias in 6.2% of participants, compared with 2.3% for the 24-hour Holter and 2.3% for 7-day event recordings. The rate difference between the 7-day Holter and the shorter or event-based approaches was 1.9% to 6.0% with a statistically significant P value. That gap is clinically plausible: continuous rhythm capture across several days is more likely to catch transient tachyarrhythmia or bradyarrhythmia episodes than a brief single-day recording, while event-only monitoring depends on a child recognizing and activating the device at exactly the right moment.
The physiology behind the yield difference is straightforward. Pediatric arrhythmias can be paroxysmal, and their frequency may not match the narrow window of conventional Holter testing. A longer continuous recording increases the chance of catching a short supraventricular tachycardia burst, intermittent atrioventricular block, or episodic sinus pauses that would otherwise disappear between clinic visits. By contrast, event recorders are powerful when symptoms are obvious and the child can respond quickly, but they are less reliable when episodes are abrupt, brief, or too subtle for activation. The continuous 7-day format also limits dependence on symptom perception, which matters in younger children and in those whose palpitations are difficult to describe.
Symptom-Rhythm Correlation and the Bedside Consequences of Longer Monitoring
The study used the final 1-year arrhythmia diagnosis as the reference standard, which strengthens the clinical relevance of the monitoring comparison. Rather than treating isolated monitor tracings as the whole story, the investigators anchored interpretation to the eventual rhythm diagnosis over follow-up. That design choice reflects everyday pediatrics, where a child may have one unrevealing tracing early on and still receive a later diagnosis after repeated symptoms or additional testing.
Arrhythmias were classified as major when they reflected tachyarrhythmia or bradyarrhythmia and as minor when they were extrasystolic. That distinction matters at the bedside because not every irregular beat carries the same downstream consequence. Minor ectopy may reassure families and spare children invasive testing, while major arrhythmia detection can alter the treatment path, especially if episodes are recurrent, hemodynamically relevant, or associated with syncope. The study’s primary outcome focused on arrhythmia detection, while the secondary outcome examined change in clinical management attributable to monitoring findings.
The practical implication is not subtle. When a child’s symptoms are sporadic, a short monitor can produce a false sense of security simply because the arrhythmia did not happen during the recording period. A 7-day continuous Holter increases the odds that the biology of the rhythm disturbance and the logistics of monitoring finally overlap. It is also a more forgiving platform for children and families who may not activate an event recorder at the exact moment symptoms occur, whether because the episode is too brief, the child is frightened, or the parent was not present.
The analyzable duration, averaging 4.9 days, also suggests that the observed gain came from a realistic amount of usable data rather than an idealized full week captured without interruption. That detail supports the feasibility of longer ambulatory monitoring in routine pediatric practice. Even when the full seven days are not analyzable, the additional time still appears to improve the chance of diagnosing clinically meaningful arrhythmias.
What this study does not resolve is how best to choose among modalities for each clinical presentation. Children with frequent palpitations, syncope, suspected bradycardia, or a prior nondiagnostic Holter may benefit most from longer continuous monitoring, while others with highly recognizable symptoms might still do well with event-based capture. The cohort was single-center, and the analysis reflects one institution’s outpatient clinic and inpatient ward experience. Broader validation in other pediatric settings will be important, especially because monitoring strategy can be shaped by age, symptom pattern, family engagement, and access to equipment.
Even with those boundaries, the central signal is hard to ignore. In a pediatric population where transient arrhythmias are easy to miss, a 7-day continuous Holter found more major rhythm disease than a 24-hour recording or an event-based strategy. For clinicians evaluating children with intermittent palpitations or unexplained symptoms, longer continuous monitoring may be the more reliable route to a diagnosis that actually changes care.